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Justin A. Shaya,4 and Aimee K. Armstrong,1 MD
Objectives: To examine acute and mid-term patient outcomes following the hybrid
approach to pulmonary atresia with intact ventricular septum (PA-IVS) compared with the
standard surgical approach. Background: A subset of PA-IVS patients with the prospect
of biventricular circulation typically undergo surgical or transcatheter right ventricular
(RV) outflow tract opening. A recently described hybrid procedure, involving perventricu-
lar pulmonary valve perforation, was shown to be safe and effective in single-center se-
ries. Methods: A single-center retrospective review of all patient with PA-IVS who
underwent either surgical or hybrid RV decompression between January 2002 and De-
cember 2011 was completed and acute and mid-term patient outcomes were compared
between the surgical and hybrid cohorts. Additionally, a systematic literature review was
completed to compare a transcatheter cohort to the hybrid cohort. Results: Seven
patients with PA-IVS underwent a hybrid procedure; the procedure was technically suc-
cessful in all attempts, and none required CPB. No patients required surgical re-
intervention prior to hospital discharge, and none died during the study period. Surgical
RV decompression was performed in 17 patients with a median CPB time of 80 min.
Patient outcomes were nearly identical between cohorts. By systematic review, the
transcatheter approach has a procedural success of 75–95% but up to 75% of patients
require operation in the neonatal period. Conclusions: The hybrid approach is a safe and
feasible alternative to the standard surgical and transcatheter approaches to PA-IVS.
Acute and mid-term patient outcomes are comparable with those treated with a standard
surgical approach and neonatal CPB is completely avoided. VC 2013 Wiley Periodicals, Inc.
Key words: congenital heart defect; patient outcome assessment; pediatric interven-
tions; perventricular procedure; hybrid cardiac surgery
INTRODUCTION
Pulmonary atresia with intact ventricular septum
(PA-IVS) is a rare form of complex congenital heart
disease with significant morphologic heterogeneity.
Because of this heterogeneity, repair or palliation strat-
egies vary widely, ranging from single ventricle
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palliation to complete biventricular repair. Overall,
regardless of anatomical subtype, survival is poor,
reported to be as low as 50% at 5 years [1–5]. For
patients with anatomy favorable for a biventricular
repair (i.e., adequate tricuspid valve, adequate right
ventricle, and no evidence of right ventricular depend-
ent coronary circulation), the initial procedural focus is
on creation of a patent right ventricular outflow tract
(RVOT) to decompress the right ventricle and to allow
for anterograde pulmonary blood flow. This procedure
may be performed surgically or percutaneously and, in
select patients, might result in growth of the right ven-
tricle [6,7] with the ability to proceed to a biventricular
circulation [1,2]. Both techniques, however, have
limitations and risks. The surgical approach requires a
sternotomy and cardiopulmonary bypass (CPB) and has
1- and 5-year survival rates of 70–75% and 60–67%,
respectively [1–3]. With risk-stratification based on
several morphologic criteria, however, the mid-term
survival rate was as high as 98% in one series [5]. The
percutaneous transcatheter approach, which involves
pulmonary valve perforation (via directed stiff guide-
wire, laser-assisted, or radiofrequency-assisted perfora-
tion) and balloon valvuloplasty, avoids sternotomy and
CPB but has a variable rate of procedural failure (5–
25%), a significant risk of cardiac perforation (5–50%),
a procedural mortality of up to 17%, and hospital mor-
tality of up to 50% [6–14]. In addition, patients treated
with the percutaneous approach have a significant risk
(up to 76%) of requiring surgical intervention in the
neonatal period either to augment pulmonary blood
flow or to repair a complication associated with the
initial transcatheter procedure [4,6,7,9–13].
Recently, a hybrid approach combining surgical
access with a transcatheter intervention to open the
RVOT was described [15]. Potential advantages of the
hybrid approach include avoidance of neonatal CPB,
mitigation of the technical failure rate of the percutane-
ous approach, due to direct access to the RVOT, and a
lower complication rate (i.e., no risk of RVOT perfora-
tion and associated sequelae) [16–19]. While the
hybrid balloon pulmonary valvuloplasty procedure has
been detailed in limited case reports and a single-
center series, it has yet to be compared rigorously with
a contemporaneous cohort treated with the standard
surgical approach. We sought to compare acute and
mid-term outcomes following the hybrid approach to
the standard surgical approach in initial treatment of
pulmonary atresia with intact ventricular septum.
METHODS
After obtaining institutional review board approval,
we performed a single-center review of all patients
with PA-IVS who underwent an RV decompression
procedure between January 2002 and December 2011.
Patients were identified using a combination of our in-
ternal surgical database (LUMEDX Corporation, Oak-
land, CA) and by performing a keyword search in our
electronic medical record system (CareWeb, non-
commercial, live since 1998) for the terms “pulmonary
atresia” and “intact ventricular septum.” Medical re-
cord review was completed to ensure only patients
who underwent RV decompression as the initial surgi-
cal repair were included in the analysis. At our institu-
tion, the hybrid approach to PA-IVS was instituted in
October 2010; previously, the surgical approach was
the treatment of choice and subsequently, only 2
patients were managed with the surgical approach.
Patients who underwent a hybrid procedure for PA-
IVS were identified by search of the institutional
hybrid procedure database. Data were collected on all
patients to assess baseline demographic information,
pre-operative procedural risk factors and echocardio-
graphic assessment of cardiac structure and function,
as well as post-procedural patient outcomes during the
initial hospitalization and for 2 years following the pro-
cedure. Whenever possible, all echocardiographic
assessments, measurements and grading were per-
formed by the core Pediatric Cardiology Echocardiog-
raphy Laboratory at our institution.
Normally distributed variables were compared using
Students t-test. Chi square was used to compare cate-
gorical variables, and nonparametric, ordinal variables
were compared using Wilcoxon Rank Sum. A P value
of< 0.05 was considered statistically significant.
A systematic review of the literature was performed
to examine patient outcomes after the percutaneous
transcatheter treatment of PA-IVS. Using key word
searches for the following terms and combination of
terms: “pulmonary atresia,” “intact ventricular septum,”
“perforation,” “transcatheter,” and “percutaneous,” we
searched the English language literature with PubMed
and OVID databases for all studies published between
1997 and 2012. Inclusion criteria for the literature
search were single center studies, multi-center studies,
and published systematic reviews or meta-analyses
which focused on patient outcomes. Exclusion criteria
were case reports or duplications of previously pub-
lished data. All references were evaluated from the
manuscripts to confirm inclusion of all pertinent stud-
ies. Specific data collected during the systematic
review included rates of procedural success/failure,
procedural complications including RVOT perforations
and mortality, need for subsequent cardiac operation(s),
and rate of achieving an eventual biventricular circula-
tion. Descriptive comparison between the percutaneous
transcatheter and hybrid cohorts was performed.
754 Zampi et al.
Catheterization and Cardiovascular Interventions DOI 10.1002/ccd.
Published on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
Hybrid Procedural Description
A midline sternotomy is performed and the pericar-
dium suspended. Circumferential control of the ductus
arteriosus is obtained. Using transesophageal echocardio-
graphic (TEE) guidance exclusively, a location on the
right ventricular free wall which will allow a straight
path to the pulmonary valve is identified, and a pledg-
eted pursestring suture is placed. A 22-gauge needle is
then inserted through the pursestring and directed across
the atretic pulmonary valve into the main pulmonary ar-
tery under TEE guidance. A guidewire is then advanced
through the needle, into the main pulmonary artery,
across the ductus arteriosus and down the descending
aorta. The needle is removed over the wire, and a 4
French sheath cut to a length of 2 cm is advanced over
the wire into the RVOT. Serial balloon pulmonary val-
vuloplasty is performed over the wire. The largest bal-
loon diameter is selected to be approximately 110–
120% of the pulmonary annulus, as measured by echo-
cardiogram. After the final balloon dilation, the ductus
arteriosus snare is engaged and the sheath is attached to
a pressure transducer to measure right ventricle pressure.
If the patient develops systemic desaturation, the ductal
snare is released and an off-CPB modified Blalock-
Taussig (BT) shunt is added. The ductus arteriosus is
then ligated. If the patient remains hemodynamically
stable with adequate oxygen saturations and subsystemic
RV pressure with the ductus snared, then the ductus is
ligated without addition of a BT shunt.
RESULTS
Baseline Characteristics
Twenty-four patients underwent an RV decompres-
sion procedure during the study period. The surgical
cohort consisted of 17 patients who underwent transan-
nular patch placement (n¼ 12) or pulmonary valvot-
omy (n¼ 5). All surgical patients received a BT shunt.
The hybrid cohort consisted of 7 patients who under-
went perventricular transcatheter balloon pulmonary
valvuloplasty, of which 5 (71%) underwent concomi-
tant placement of a BT shunt.
The baseline clinical characteristics and pre-
operative risk factors for the cohorts are shown in Ta-
ble I. There were no differences between the cohorts in
gender, age, weight, gestational age, genetic or noncar-
diac anomalies, preoperative echocardiographic assess-
ment of right heart size or function, or the presence of
RV sinusoids as assessed by echocardiogram. Although
uncommon in the cohort overall, preoperative use of
extracorporeal membrane oxygenation (ECMO) support
and the presence of extracardiac organ system dysfunc-
tion were only present in the hybrid group.
Hospital Outcomes
There were no significant differences between
cohorts in the maximum vasoactive-inotropic score
(VIS), duration of mechanical ventilation, length of in-
tensive care unit stays, or overall length of hospital
stay (Table II). The overall complication rate was simi-
lar for both cohorts. There was no in-hospital mortality
in the study population during the initial hospital stay.
One patient in the surgical cohort required reoperation
prior to hospital discharge for placement of a right
ventricle to pulmonary artery conduit due to persistent
cyanosis. No patient in the hybrid cohort required a
repeat surgical intervention during the initial hospital
stay, although 1 patient in this cohort underwent percu-
taneous pulmonary valvuloplasty. No patient in the
hybrid cohort required CPB at the initial palliative pro-
cedure or at any other time prior to hospital discharge.
Median CPB time in the surgical cohort was 80 min
(IQR 69–108 min).
At hospital discharge, median oxygen saturations
were not different between cohorts.
Post-Discharge Outcomes
During the 2-year follow-up period, there were 2
deaths in the surgical cohort (11.8%) and none in the
hybrid cohort (Table III). One patient died suddenly at
home 14 days after hospital discharge, and one patient
died peri-operatively following a Nissen fundoplica-
tion, 15 months after the initial surgical palliation.
The number of patients who underwent elective BT
shunt occlusion or ASD closure procedures, either surgi-
cally or percutaneously, was not different between the
cohorts. Excluding these procedures, 6 patients (35%) in
the surgical cohort required an additional surgical proce-
dure, including augmentation of the RVOT (n¼ 3),
RPA augmentation (n¼ 1), and hemiFontan procedure
(superior cavopulmonary anastomosis) for single ventri-
cle palliation (n¼ 1); the sixth patient underwent sur-
gery prior to hospital discharge as described above. Four
patients in the surgical cohort (24%) underwent inter-
ventional catheterization procedures for pulmonary bal-
loon valvuloplasty (n¼ 2), branch pulmonary artery
angioplasty (n¼ 1), and branch pulmonary artery stent
placement (n¼ 1). In comparison, 1 patient (14%) in the
hybrid cohort underwent cardiac surgery for patch aug-
mentation of the RVOT and bidirectional Glenn anasto-
mosis (11=2 ventricle repair) and 2 patients (29%)
underwent percutaneous pulmonary balloon valvulo-
plasty (includes the 1 patient who underwent pulmonary
balloon valvuloplasty prior to initial hospital discharge).
Of note, the two patients who underwent pulmonary bal-
loon valvuloplasty after the hybrid procedure were the
same two patients who did not have a BT shunt placed
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at the time of the initial procedure. The valvuloplasty
was performed at a median of 41 days (range, 37–45
days) after the initial procedure.
At 1- and 2-year follow-up visits, median oxygen
saturation was 89.5% and 92% for the surgical cohort
and 93% and 95% for the hybrid cohort, respectively.
Echocardiographic assessment of right heart size and
function was nearly identical between the two
cohorts at 1- and 2-year follow-up, as demonstrated in
Table IV.
The rates of eventual biventricular circulation were
82% and 86% for the surgical and hybrid cohorts,
respectively, with only one patient requiring single
ventricle palliation (surgical cohort). The remaining 3
patients (surgical cohort n¼ 2, and hybrid cohort
n¼ 1) underwent a 11=2 ventricle palliation (RV-PA
connection plus cavopulmonary anastomosis).
Systematic Review of Percutaneous
Transcatheter Approach
There were 8 manuscripts published between 1998
and 2012 describing percutaneous transcatheter proce-
dures for the initial palliation of PA-IVS performed
TABLE I. Demographic and Clinical Characteristics
Approach
Characteristics All Surgical (n ¼ 17) Hybrid (n ¼ 7) P-valuea
Male sex 12 (50.0) 10 (58.8) 2 (28.6) 0.37
Age at surgery, days 6 (0–14) 5 (0–14) 7 (5–12) 0.06
Weight at surgery, kg 3.0 (1.4–4.3) 3.0 (1.5–4.3) 3.1 (1.4–4.0) 0.92
Body surface area at surgery, mb 0.21 (0.13–0.25) 0.20 (0.14–0.25) 0.21 (0.13–0.23) 0.95
Non-cardiac abnormality 1 (4.2) 1 (5.9) 0 (0.0) 1.00
Genetic syndrome 0 (0.0) 0 (0.0) 0 (0.0) N/A
Gestational age, weeks 39 (30–41) 39 (32–41) 39 (30–41) 1.00
Pre-Operative
ECMO 1 (4.2) 0 (0.0) 1 (14.3) 0.29
Mechanical ventilation 15 (62.5) 10 (58.8) 5 (71.4) 0.67
Organ system dysfunction 2 (8.3) 0 (0.0) 2 (28.6) 0.08
Pre-Operative Echocardiographic Measurements
Tricuspid valve size, mm 10.0 (6.5–15.1) 10.0 (6.9–15.1) 8.5 (6.5–13.3) 0.41
Tricuspid valve z-score 0.48 (3.1–4) 0.36 (2.5–4) 1.3 (3.1–3.2) 0.47
Tricuspid regurgitation
None/Trivial 1 (4.2) 0 (0.0) 1 (14.3)
Mild 2 (8.3) 2 (11.8) 0 (0.0)
Mild to Moderate 5 (20.8) 4 (23.5) 1 (14.3) 1.00b
Moderate 11 (45.8) 7 (41.2) 4 (57.1)
Moderate to Severe 5 (20.8) 4 (23.5) 1 (14.3)
RV size
Normal 5 (20.8) 3 (17.6) 2 (28.6)
Mildly hypoplastic 9 (37.5) 7 (41.2) 2 (28.6)
Moderately hypoplastic 6 (25.0) 3 (17.6) 3 (42.9) 0.64c
Severely hypoplastic 1 (4.2) 1 (5.9) 0 (0.0)
Unknown 3 (12.5) 3 (17.6) 0 (0.0)
RV systolic function
Normal 1 (4.2) 0 (0.0) 1 (14.3)
Mildly depressed 0 (0.0) 0 (0.0) 0 (0.0) 0.29d
Moderately depressed 10 (41.7) 9 (52.9) 1 (14.3)
Severely depressed 13 (54.2) 8 (47.1) 5 (71.4)
Pulmonary valve annulus size, mm 6 (2.9–8.2) 6.2 (2.9–8.2) 6 (4–7) 0.55
Pulmonary valve annulus z-score 1.5 (3.7– 0.1) 1.45 (3.7– 0.1) 1.8 (3.4– 0.5) 0.89
Sinusoids present (non-RV dependent) 11 (45.8) 8 (47.1) 3 (42.9) 1.00
Abbreviations: ECMO, extracorporeal membrane oxygenation; RV, right ventricular; N/A, not applicable.
* Data are presented as N (%) for categorical variables and Median (min-Max) for continuous variables.
aP-value from Fisher’s exact test for categorical variables and Wilcoxon Rank Sum test for continuous variables on comparison of each characteristic
between two approaches (surgical vs. hybrid).
bComparison was made between None/trivial/Mild/Mild-to-Moderate vs. Moderate/Moderate-to-Severe and p-value was from Fisher’s exact test.
cComparison was made between Normal/mildly hypoplastic vs. moderately/severely hypoplastic and p-value was from Fisher’s exact test.
dComparison was made between Normal/mildly depressed vs. moderately/severely depressed and p-value was from Fisher’s exact test.
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between 1990 and 2010. All were single-center studies,
except the article by Bensen et al., which included data
published in 15 studies between 1993 and 2002. Thus
the total number of studies included in the systemic
review was 22. In this cohort of 267 patients, the pro-
cedural success was 75–95%. Procedural complication
rates were 15–75%, with RVOT perforation occurring
in 5–50% of procedures. Procedural mortality was
5.6% with an overall mortality rate (during study
follow-up periods) of 0–50%, and 33–75% of patients
required a surgical procedure in the neonatal period
with indications of augmenting pulmonary blood flow
(71%), transcatheter procedural failure (18%) and
cardiac perforation repair (8%). Patients went on to
biventricular circulation in 80% of cases.
DISCUSSION
In patients with PA-IVS and anatomy favorable for
a future biventricular repair, the hybrid approach to ini-
tial palliation offers a safe and feasible alternative to
surgical and percutaneous techniques for RV decom-
pression. In our single-center experience with the
hybrid approach to RV decompression, we achieved a
100% procedural success rate with no peri-procedural
mortality. Moreover, no hybrid-treated patient required
CPB in the neonatal period and both acute and mid-
term outcomes did not differ significantly from those
treated with the standard surgical approach.
Comparison With the Surgical Approach
Compared to standard surgical approaches for the
initial treatment of PA-IVS, the hybrid approach
achieved nearly identical rates of procedural success
and peri-procedural complications, in cohorts with no
baseline differences. Likewise, the acute and mid-term
patient outcomes are similar between cohorts.
Avoidance of CPB in the neonatal period is a major
advantage of the hybrid approach in this patient
TABLE II. Hospital Outcomes and Complications
Approach
Surgical Hybrid
Outcomes/Complications All (n ¼ 17) (n ¼ 7) P-valuea
Maximum vasoactive-inotropic scoreb 17 (5–34) 18 (5–34) 8 (5–28) 0.25
Length of intubation, days 5 (2–20) 4 (2–12) 8 (3–20) 0.08
ICU length of stay, days 6 (4–58) 6 (4–25) 11 (4–58) 0.21
Hospital length of stay, days 17.5 (8–129) 18 (8–38) 17 (8–129) 0.83
Post-operative ECMO 1 (4.2) 0 (0.0) 1 (14.3) 0.29
Re-operation prior to hospital discharge 1 (4.2) 1 (5.9) 0 (0.0) 1.00
Interventional cardiac catheterization prior to hospital discharge 1 (4.2) 0 (0.0) 1 (14.3) 0.29
PA repair prior to hospital discharge 0 (0.0) 0 (0.0) 0 (0.0) N/A
Oxygen saturation levels at hospital discharge (%) 85 (75–97) 84.5 (75–97) 86 (81–97) 0.29
Any complications 14 (58.3) 10 (58.8) 4 (57.1) 1.00
Arrhythmia 4 (16.7) 3 (17.6) 1 (14.3) 1.00
Cardiac arrest 2 (8.3) 2 (11.8) 0 (0.0) 1.00
Renal insufficiency or failure 3 (12.5) 1 (5.9) 2 (28.6) 0.19
Neurologic injury or seizure 0 (0.0) 0 (0.0) 0 (0.0) N/A
Infections 5 (20.8) 3 (17.6) 2 (28.6) 0.61
NEC 5 (20.8) 4 (23.5) 1 (14.3) 1.00
Death 0 (0.0) 0 (0.0) 0 (0.0) N/A
Other 1 (4.2) 1 (5.9) 0 (0.0) 1.00
Discharge echocardiogram datac
RVOT gradient n ¼ 19 n ¼ 14 n ¼ 5
“None” (n) 10 (52.6) 8 (57.1) 2 (40.0) 0.63
PIPG (mmHg) 22 (10–60) 21 (10–32) 30 (22–60) 0.14
RV pressure n ¼ 18 n ¼ 12 n ¼ 6
TR velocity (mmHg þ right atrial pressure) 35 (27–70) 35 (27–54) 38 (28–70) 0.93
Age at time of echocardiogram (days) n ¼ 21 n ¼ 15 n ¼ 6
21 (10–139) 20 (10–94) 24 (12–139) 0.68
Abbreviations: ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation; NEC, necrotizing enterocolitis; PA, pulmonary artery; N/A,
not applicable; RVOT, right ventricular outflow tract; PIPG, peak instantaneous pressure gradient; RV, right ventricle; TR, tricuspid regurgitation.
* Data are presented as N (%) for categorical variables and Median (min-Max) for continuous variables.
aP-value from Fisher’s exact test for categorical variables and Wilcoxon Rank Sum test for continuous variables on comparison of each outcome
between two approaches (surgical vs. hybrid).
bHighest hourly vasoactive-inotropic score in the first 48 hours after the initial procedure.
cBased on echocardiogram performed in closest proximity but prior to discharge from the hospital
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population. Neonatal CPB has both acute consequences
related to systemic inflammatory response as well as
longer term impact on end-organ development and neu-
rocognitive and psychomotor function [20–30].
Unfortunately, the acute impact of CPB is difficult to
assess. In this study, maximal vaso-active inotropic
score, which has been used to predict early post-
operative outcome in neonates after cardiac surgery,
was not statistically different between cohorts [31–33].
Similarly, the long-term impact of CPB will likely
require long-term follow-up with performance of neu-
rocognitive testing. Thus, the most important advantage
of the hybrid approach may require many years to be
realized.
Comparison With the Percutaneous Approach
The major differences between the percutaneous and
hybrid approaches to PA-IVS are the lower rates of
procedural success, higher rates of procedural compli-
cations, and higher mortality for the percutaneous
cohort. The risk of RVOT perforation is eliminated by
the surgical and hybrid approaches. Most importantly,
there is a high rate of neonatal surgery required in the
percutaneous cohort. These operations are usually per-
formed secondary to inadequate pulmonary blood flow
following the initial percutaneous transcatheter proce-
dure, but are also sometimes required because of pro-
cedural failure and RVOT perforations. While the
percutaneous transcatheter approach theoretically
avoids CPB, it is clear that this approach does not
avoid CPB in up to 33–75% of patients.
FUTURE APPROACHES AND STUDIES
In our study, off-CPB BT shunts were placed at the
time of the initial procedure for patients who underwent
the hybrid approach and experienced a precipitous
decrease in oxygen saturations with occlusion of the duc-
tus arteriosus. There are two alternatives to this
approach. First, ductal patency could be maintained with
a continued prostaglandin infusion. Even with adequate
balloon valvuloplasty, the primary limitations to antero-
grade pulmonary blood flow are poor RV compliance
and sub-valvar infundibular obstruction due to RV hyper-
trophy. In many patients, these improve with time and
watchful waiting may obviate the need for placement of
an additional source of pulmonary blood flow (e.g. a BT
shunt). This approach, however, requires prolonged hos-
pitalization for prostaglandin infusion, exposes patients
to the risks of chronic prostaglandin administration, and
places a subset of patients at risk during a second cardio-
thoracic surgical procedure [34–36]. A second alternative
is to stent the ductus arteriosus in lieu of placing a BT
shunt. Ductal stenting is now commonly performed as a
palliative procedure in several forms of congenital heart
disease and has been described for patients with PA-IVS
[8,37–42]. The procedural success rate, peri-operative
complication profile, and long-term impact on future
operations and pulmonary artery anatomy, however, are
not yet available. Thus, while maintaining ductal patency
with prostaglandin infusion or stent implantation are via-
ble alternatives to placement of a BT shunt, the relative
risks and benefits require further study to determine the
optimal approach.
TABLE III. Post-Discharge Outcomes
Approach
Surgical Hybrid
Outcomes All (n ¼ 17) (n ¼ 7) P-valuea
Re-operation within 2 years of procedure 10 (41.7) 8 (47.1) 2 (28.6) 0.65
Excluding BT shunt occlusion and ASD closure 7 (29.2) 6 (35.3) 1 (14.2) 0.65
Interventional cardiac catheterization within 2 years of procedure 10 (41.7) 6 (35.3) 4 (57.1) 0.39
Excluding BT shunt occlusion and ASD closure 6 (25.0) 4 (23.5) 2 (28.6) 1.00
PA repair within 2 years of procedure 5 (20.8) 5 (29.4) 0 (0.0) 0.27
Oxygen saturation levels
at 1 year post-operation (n ¼ 20) 91.5 (81–100) 89.5 (81–100) 93 (85–97) 0.97
at 2 year post-operation (n ¼ 15) 93 (83–100) 92 (83–100) 95 (85–98) 0.23
Current physiology
1V 1 (4.2) 1 (5.9) 0 (0.0)
1.5V 3 (12.5) 2 (11.8) 1 (14.3) 1.00b
2V 20 (83.3) 14 (82.3) 6 (85.7)
Current patient status (Dead) 2 (8.3) 2 (11.8) 0 (0.0) 1.00
Abbreviations: BT, Blalock-Taussig; PA, pulmonary artery; V, ventricle.
* Data are presented as N (%) for categorical variables and Median (min-Max) for continuous variables.
aP-value from Fisher’s exact test for categorical variables and Wilcoxon Rank Sum test for continuous variables on comparison of each outcome/
complication between two approaches (surgical vs. hybrid).
bComparison was made between 1V or 1.5V vs. 2V and p-value was from Fisher’s exact test.
758 Zampi et al.
Catheterization and Cardiovascular Interventions DOI 10.1002/ccd.
Published on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
As mentioned above, long-term follow-up of these
patient cohorts might help delineate the impact of cardio-
pulmonary bypass on neurodevelopmental outcomes.
Since the acute- and mid-term outcomes of the hybrid
and surgical approaches to PA-IVS are similar, this patient
population might be ideal to evaluate the long term neuro-
developmental outcomes of CPB. This would be best
approached in a multi-institutional trial, given the rarity of
PA-IVS, especially the morphologic variant amenable to
RV decompression and possible biventricular repair.
LIMITATIONS
The major limitations of our study are the small sample
size, the retrospective approach, and the lack of a con-
comitant local percutaneous transcatheter-treated cohort
with which to compare the surgical and hybrid groups. At
our institution, the transcatheter approach for patients with
PA-IVS is seldom performed. While we have attempted
to compare descriptively the hybrid approach to the percu-
taneous transcatheter approach, the systematic literature
review includes procedures performed as early as 1990.
The recent increased use of radiofrequency-guided pulmo-
nary valve perforation in PA-IVS may result in increased
procedural safety. Even the most contemporary studies,
however, have relatively high procedural complication
rates and, most importantly, a large number of patients
requiring subsequent neonatal operations following the ini-
tial transcatheter approach to therapy.
CONCLUSIONS
This is the first study to compare the hybrid
approach for RV decompression in PA-IVS to the
TABLE IV. Echocardiographic Characteristics at 1- and 2-Year Follow-Upa
Surgical Approach Hybrid Approach P-valueb
1-year
n¼ 14
2-year
n¼ 10
1-year
n¼ 6
2-year
n¼ 6 1-year 2-year
Tricuspid regurgitation
Less than moderate 11 (78.6) 7 (70.0) 5 (83.3) 4 (66.7) 1.00c 1.00c
Moderate or severe 3 (21.4) 3 (30.0) 1 (16.7) 2 (33.3)
Tricuspid stenosis
None or trivial 13 (92.9) 10 (100.0) 6 (100.0) 6 (100.0) 1.00 N/A
Moderate 1 (7.1) 0 (0.0) 0 (0.0) 0 (0.0)
RV size
Normal to mildly hypoplastic 9 (64.3) 10 (100.0) 6 (100.0) 6 (100.0) 0.51d N/Ad
Moderate or severely hypoplastic 3 (21.4) 0 (0.0) 0 (0.0) 0 (0.0)
RV systolic function
Less than moderately depressed 12 (85.7) 10 (100.0) 6 (100.0) 6 (100.0) 1.00e N/Ae
Moderate or severely depressed 1 (7.1) 0 (0.0) 0 (0.0) 0 (0.0)
Pulmonary stenosis
None/trivial 12 (85.7) 9 (90.0) 6 (100.0) 6 (100.0)
Mild 1 (7.1) 0 (0.0) 0 (0.0) 0 (0.0) 1.00 1.00
Moderate 0 (0.0) 1 (10.0) 0 (0.0) 0 (0.0)
Pulmonary insufficiency
Moderate or less 1 (7.1) 0 (0.0) 1 (16.7) 2 (33.3) 1.00f 0.13f
Severe 12 (85.7) 10 (100.0) 5 (83.3) 4 (66.7)
ASD direction of shunting
R!L 5 (35.7) 3 (30.0) 3 (50.0) 3 (50.0)
Bidirectional with R!L 4 (28.6) 4 (40.0) 0 (0.0) 1 (16.7) N/A N/A
Bidirectional 2 (14.3) 1 (10.0) 3 (50.0) 2 (33.3)
No shunt or no ASD 1 (7.1) 2 (20.0) 0 (0.0) 0 (0.0)
RV, right ventricular; ASD, atrial septal defect; R-to-L, right to left; N/A, not applicable.
Data are presented as N (%).
aWhenever possible, echocardiographic assessment and subjective grading was performed by the core Pediatric Cardiology Echocardiography Labora-
tory at our institution. For 4 patients, 3 in the surgical cohort and 1 in the hybrid cohort, review of the echocardiographic images was not available
and data presented are based on review of echocardiography reports.
bP-value from Fisher’s exact test for categorical variables and Wilcoxon Rank Sum test for continuous variables on comparison of each characteristic
between two approaches (surgical vs. hybrid).
cComparison was made between None/trivial/Mild/Mild-to-Moderate vs. Moderate/Moderate-to-Severe and P-value was from Fisher’s exact test.
dComparison was made between Normal/mildly hypoplastic vs. moderately/severely hypoplastic and P-value was from Fisher’s exact test.
eComparison was made between Normal/mildly depressed vs. moderately/severely depressed and P-value was from Fisher’s exact test.
fComparison was made between Mild to Moderate/Moderate vs. Severe and P-value was from Fisher’s exact test and P-value was from Fisher’s
exact test.
Hybrid Approach to PA-IVS 759
Catheterization and Cardiovascular Interventions DOI 10.1002/ccd.
Published on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
standard surgical and percutaneous approaches. The
hybrid approach is a safe and feasible alternative with
a high rate of technical success and low rate of proce-
dural complications. Overall, the acute- and mid-term
patient outcomes are comparable to those treated with
a standard surgical approach. In addition, use of the
hybrid procedure avoids neonatal exposure to CPB,
which may have long-term detrimental effects, particu-
larly in neonates.
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